Business Description
MannKind Corp
NAICS : 325412
SIC : 2834
ISIN : US56400P7069
Share Class Description:
MNKD: Ordinary SharesDescription
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.05 | |||||
| Equity-to-Asset | -0.45 | |||||
| Debt-to-Equity | -1.15 | |||||
| Debt-to-EBITDA | 3.49 | |||||
| Interest Coverage | 1.6 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | -6.4 | |||||
| Beneish M-Score | -1.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 36.5 | |||||
| 3-Year EPS without NRI Growth Rate | 39.7 | |||||
| 3-Year FCF Growth Rate | 40.6 | |||||
| 3-Year Book Growth Rate | -7 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 23.81 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.65 | |||||
| 9-Day RSI | 36.95 | |||||
| 14-Day RSI | 41.39 | |||||
| 3-1 Month Momentum % | 11 | |||||
| 6-1 Month Momentum % | 38.1 | |||||
| 12-1 Month Momentum % | 79.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.54 | |||||
| Quick Ratio | 4.17 | |||||
| Cash Ratio | 3.49 | |||||
| Days Inventory | 129.85 | |||||
| Days Sales Outstanding | 26.82 | |||||
| Days Payable | 48.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.7 | |||||
| Shareholder Yield % | 1.55 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.91 | |||||
| Operating Margin % | 21.43 | |||||
| Net Margin % | 8.07 | |||||
| FCF Margin % | 10.81 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 4.94 | |||||
| ROIC % | 30.87 | |||||
| 3-Year ROIIC % | 45.19 | |||||
| ROC (Joel Greenblatt) % | 70.25 | |||||
| ROCE % | 17.58 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 81.75 | |||||
| Forward PE Ratio | 29.73 | |||||
| PE Ratio without NRI | 64.75 | |||||
| PS Ratio | 7.02 | |||||
| Price-to-Free-Cash-Flow | 63.5 | |||||
| Price-to-Operating-Cash-Flow | 44.19 | |||||
| EV-to-EBIT | 29.43 | |||||
| EV-to-EBITDA | 26.05 | |||||
| EV-to-Revenue | 6.71 | |||||
| EV-to-Forward-Revenue | 5.43 | |||||
| EV-to-FCF | 62.07 | |||||
| Price-to-GF-Value | 0.69 | |||||
| Earnings Yield (Greenblatt) % | 3.4 | |||||
| FCF Yield % | 1.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MNKD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MannKind Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 267.2 | ||
| EPS (TTM) ($) | 0.08 | ||
| Beta | 0.86 | ||
| 3-Year Sharpe Ratio | 0.42 | ||
| 3-Year Sortino Ratio | 0.74 | ||
| Volatility % | 34.08 | ||
| 14-Day RSI | 41.39 | ||
| 14-Day ATR ($) | 0.243251 | ||
| 20-Day SMA ($) | 6.7175 | ||
| 12-1 Month Momentum % | 79.38 | ||
| 52-Week Range ($) | 3.17 - 7.63 | ||
| Shares Outstanding (Mil) | 275.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MannKind Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MannKind Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MannKind Corp Frequently Asked Questions
What is MannKind Corp(MNKD)'s stock price today?
The current price of MNKD is $6.54. The 52 week high of MNKD is $7.63 and 52 week low is $3.17.
When is next earnings date of MannKind Corp(MNKD)?
The next earnings date of MannKind Corp(MNKD) is 2025-02-27 Est..
Does MannKind Corp(MNKD) pay dividends? If so, how much?
MannKind Corp(MNKD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers